XML 29 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Information
 9 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Segment Information
Segment Information
The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company's segments using information about its revenues, gross profit, and income from operations. Such evaluation excludes general corporate-level costs that are not specific to either of the reportable segments and are managed separately at the corporate level. Corporate-level costs include expenses related to executive management, finance and accounting, human resources, legal, training and development, and certain administrative expenses. The two operating segments, which are the same as the Company's two reportable segments, are as follows:
Automation and Analytics
The Automation and Analytics segment is organized around the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Automation and Analytics products are designed to enable the Company's customers to enhance and improve the effectiveness of the medication-use process, the efficiency of the medical-surgical supply chain, overall patient care and clinical and financial outcomes of medical facilities. Through modular configuration and upgrades, the Company's systems can be tailored to specific customer needs. The financial results of Aesynt acquired in the first quarter of 2016 are included in the Automation and Analytics segment.
Medication Adherence
The Medication Adherence segment includes primarily the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. These products are used to manage medication administration outside of the hospital setting and include medication adherence products, which consist of proprietary medication packaging systems and related products for use by institutional pharmacies servicing long-term care, and correctional facilities or retail pharmacies serving patients in their local communities.
The following table summarizes the financial performance of the Company's reportable segments, including a reconciliation of income from segment operations to income from total operations:
 
Three months ended
 
September 30, 2016
 
September 30, 2015
 
Automation and
Analytics
 
Medication
Adherence
 
Total
 
Automation and
Analytics
 
Medication
Adherence
 
Total
 
(In thousands)
Revenues
$
152,437

 
$
24,300

 
$
176,737

 
$
102,967

 
$
22,267

 
$
125,234

Cost of revenues
77,828

 
17,401

 
95,229

 
45,668

 
15,863

 
61,531

Gross profit
74,609

 
6,899

 
81,508

 
57,299

 
6,404

 
63,703

Operating expenses
49,123

 
6,137

 
55,260

 
30,628

 
6,070

 
36,698

Income from segment operations
$
25,486

 
$
762

 
$
26,248

 
$
26,671

 
$
334

 
$
27,005

Corporate costs
 
 
 
 
21,320

 
 
 
 
 
13,146

Income from operations
 
 
 
 
$
4,928

 
 
 
 
 
$
13,859



 
Nine months ended
 
September 30, 2016
 
September 30, 2015
 
Automation and
Analytics
 
Medication
Adherence
 
Total
 
Automation and
Analytics
 
Medication
Adherence
 
Total
 
(In thousands)
Revenues
$
450,043

 
$
70,605

 
$
520,648

 
$
284,447

 
$
69,796

 
$
354,243

Cost of revenues
233,401

 
47,777

 
281,178

 
123,923

 
47,470

 
171,393

Gross profit
216,642

 
22,828

 
239,470

 
160,524

 
22,326

 
182,850

Operating expenses
151,108

 
17,518

 
168,626

 
85,195

 
18,321

 
103,516

Income from segment operations
$
65,534

 
$
5,310

 
$
70,844

 
$
75,329

 
$
4,005

 
$
79,334

Corporate costs
 
 
 
 
64,182

 
 
 
 
 
42,672

Income from operations
 
 
 
 
$
6,662

 
 
 
 
 
$
36,662

________________________________________________
Significant customers
There were no customers that accounted for more than 10% of our total revenues for the three and nine months ended September 30, 2016 and September 30, 2015.
    Geographical Information
Revenues
 
Three months ended
 
September 30,
2016
 
September 30,
2015
 
(In thousands)
United States
$
155,989

 
103,944

Rest of world (1)
20,748

 
21,290

Total revenues
$
176,737

 
$
125,234

    
 
Nine months ended
 
September 30,
2016
 
September 30,
2015
 
(In thousands)
United States
$
445,470

 
$
297,564

Rest of world (1)
75,178

 
56,679

Total revenues
$
520,648

 
$
354,243

(1)    No individual country represented more than 10% of the respective totals.
  Property and equipment, net
 
September 30,
2016
 
December 31,
2015
 
(In thousands)
United States
$
36,017

 
$
29,506

Rest of world (1)
5,017

 
2,803

Total property and equipment, net
$
41,034

 
$
32,309

_________________________________________________
(1)    No individual country represented more than 10% of the respective totals.
Property and equipment, net is attributed to the geographic location in which it is located.